Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation

Dermatol Ther. 2018 Nov;31(6):e12710. doi: 10.1111/dth.12710. Epub 2018 Sep 25.

Affiliations

¹ UOC of Dermatology, Policlinico Umberto I, Sapienza University of Rome.
² Dermatology and Cosmetology Unit, San Raffaele Hospital, Milan, Italy.
³ Super Computing Applications and Innovation (SCAI), CINECA, Rome, Italy.
⁴ Klinik für Dermatologie und Allergologie, Universitätsklinikum Marburg, Marburg, Germany.
⁵ UOC of Plastic Surgery, Policlinico Umberto I, Sapienza University of Rome.
⁶ UOS of Dermatology, University of Magna Grecia, Catanzaro, Italy.

PMID: 30253027
DOI: 10.1111/dth.12710

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Aged
Aged, 80 and over
Aminolevulinic Acid / adverse effects
Aminolevulinic Acid / analogs & derivatives*
Aminolevulinic Acid / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Diclofenac / adverse effects
Diclofenac / therapeutic use*
Female
Gels
Humans
Hyaluronic Acid / adverse effects
Hyaluronic Acid / therapeutic use*
Keratosis, Actinic / diagnosis
Keratosis, Actinic / drug therapy*
Male
Middle Aged
Patient Compliance
Photochemotherapy* / adverse effects
Photosensitizing Agents / adverse effects
Photosensitizing Agents / therapeutic use*
Quality of Life
Rome
Severity of Illness Index
Skin / drug effects*
Skin / pathology
Time Factors
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Gels
Photosensitizing Agents
Diclofenac
methyl 5-aminolevulinate
Aminolevulinic Acid
Hyaluronic Acid